—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Labcorp Holdings Inc. (LH) — chart, structure and Closelooknet read

The Closelooknet read

Labcorp runs two main businesses: diagnostic laboratories that test blood, tissue and other samples for doctors and patients, and laboratory services that support drug developers running clinical trials. It offers routine tests such as blood counts and cholesterol panels alongside specialised work like genetic screening, cancer pathology and infectious-disease testing.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for LH, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 47/100 · S&P 500 fund at 48, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-06
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 60th percentile of the window, -22.8% over 20 sessions. Factor regime → 2026-11-06
  • Sovereign pressure Index -1.91 · down 2.45 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-06
How it trades on rate days beta 0.48 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How LH has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.48 — tends to move with bonds for every 1% move in TLT (20+ year Treasuries), Labcorp Holdings Inc. moved 0.48% on average · correlation 0.19 · higher than 39% of US names
  • Beta, last 3 months 0.58 about the same as over the year
  • On the 10 worst bond days −0.87% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +1.63% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against LH on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Labcorp Holdings Inc.

LH in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Labcorp runs two main businesses: diagnostic laboratories that test blood, tissue and other samples for doctors and patients, and laboratory services that support drug developers running clinical trials. It offers routine tests such as blood counts and cholesterol panels alongside specialised work like genetic screening, cancer pathology and infectious-disease testing. Its clients include patients, physicians, health plans, government programmes and pharmaceutical and biotech companies. It is based in Burlington, United States, and has begun offering a generative-AI tool that helps clinicians choose the right test.
Where it sits in the stack
Labcorp sits outside our Rubin index, which tracks the AI hardware build-out; in our wider universe it belongs to the Healthcare sector, under diagnostics and research. Its work is processing patient and trial samples rather than supplying compute, chips or data-centre infrastructure, so it is not a constraint on or customer of that stack.
Who it is priced against
Closelooknet's peer group for Labcorp is not yet defined. The name the market most often compares it with is Quest Diagnostics, the other large commercial laboratory operator in the United States.
Why Closelooknet tracks it
Labcorp holds a seat in the S&P 500 but has no seat in Rubin or Halo, and its Closelooknet score has not yet been built. The diary has not yet quoted it in an edition.
What the diary watches
The diary watches how demand splits between routine diagnostic testing and the biopharma laboratory services tied to drug trials, and whether the new generative-AI test-selection tool changes how clinicians order tests.

Labcorp Holdings Inc. (LH) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 3 analyst actions on the wire · latest: price target by Deutsche Bank, 2026-10-29

The Street on this name

Analyst actions and the latest print for LH from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Deutsche Bank — target 355 from 306 Target raised to $355 from $306 (-2.3% to spot) 2026-10-29
  • Price target UBS — target 380 from 361 Target raised to $380 from $361 (+23.6% to spot) 2026-09-11
  • Price target Barclays — target 330 from 320 Target raised to $330 from $320 (+7.5% to spot) 2026-09-11

3 actions on the analyst wire since 2026-08-13: 3 target changes. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 0.79%, quarterly · last 0.72 USD on 2026-08-28

Dividends and capital return

What LH pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.88 USD per share · a 0.79% yield on the 2026-11-06 close 4 distributions, paid quarterly 2026-11-06
  • Change on the year 0.0% against the prior twelve months prior twelve months 2.88 USD per share
  • Last distribution 0.72 USD per share as the price series records it, within days of the ex-date 2026-08-28
  • By calendar year 2024: 2.89 USD (partial) · 2025: 2.88 USD · 2026: 2.16 USD to date first distribution recorded in the three-year window: 2024-02-26

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-07

Quick answers

What is Labcorp Holdings Inc. (LH)?

Labcorp Holdings Inc. trades as LH on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-11-07.

Is LH in a Closelooknet index?

Not currently — Labcorp Holdings Inc. is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-07.

Where does LH trade against its moving averages?

Labcorp Holdings Inc. trades 12.6% above its 50-day and 26.7% above its 200-day moving average (8.3% above its 20-day). As of 2026-11-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Labcorp Holdings Inc. compare with its peers?

Against its peer group (Diagnostics & Research · United States), Labcorp Holdings Inc. (LH) sits 1.8% below its 52-week high, 12.6% above its 50-day average; Mettler-Toledo International Inc (MTD) is 4.7% below, Charles River Laboratories (CRL) is 11.1% below, Qiagen NV (QGEN) is 13.0% below, as of 2026-11-06. Put any of them next to LH in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Labcorp Holdings Inc. trade when bond yields rise?

Over the past year Labcorp Holdings Inc. had a beta of 0.48 to TLT, the long-dated Treasury fund — it tends to move with bonds, higher than 39% of US names. On the 10 sessions in which long bonds fell most it moved −0.87% on average, against −0.74% for the S&P 500. As of 2026-11-06; The "How it trades on rate days" block on this page carries the lines.

What does Labcorp Holdings Inc. do?

Labcorp runs two main businesses: diagnostic laboratories that test blood, tissue and other samples for doctors and patients, and laboratory services that support drug developers running clinical trials. It offers routine tests such as blood counts and cholesterol panels alongside specialised work like genetic screening, cancer pathology and infectious-disease testing. Its clients include patients, physicians, health plans, government programmes and pharmaceutical and biotech companies. Closelooknet's peer group for Labcorp is not yet defined. The name the market most often compares it with is Quest Diagnostics, the other large commercial laboratory operator in the United States. (Company snapshot of 2026-09-17.)

Where does Labcorp Holdings Inc. sit in the AI build-out?

Labcorp sits outside our Rubin index, which tracks the AI hardware build-out; in our wider universe it belongs to the Healthcare sector, under diagnostics and research. Its work is processing patient and trial samples rather than supplying compute, chips or data-centre infrastructure, so it is not a constraint on or customer of that stack. Labcorp holds a seat in the S&P 500 but has no seat in Rubin or Halo, and its Closelooknet score has not yet been built. The diary has not yet quoted it in an edition. (Company snapshot of 2026-09-17.)

Does Labcorp Holdings Inc. pay a dividend?

Labcorp Holdings Inc. has paid 2.88 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.79% on the 2026-11-06 close; the last distribution recorded in the price series was 0.72 USD on 2026-08-28. As of 2026-11-06; the "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Labcorp Holdings Inc. recently?

The most recent analyst action on Labcorp Holdings Inc. on the Closelooknet wire is a price target by Deutsche Bank on 2026-10-29 (target 355 from 306). 3 actions on the analyst wire since 2026-08-13: 3 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for LH, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.